₹5.77
₹-0.06 (-1.03%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹75 Cr
P/E
52.45
ROE
0.41%
ROCE
0.72%
About IEL Ltd
IEL is in the business of manufacturing, trading and marketing of all kinds of chemicals, pharmaceuticals, drug intermediates etc., as also is into the business or trade or activities of providing services in the areas of warehousing, leasing, renting, hire-purchase, market support services, distributors, information technology consultancy or related products, health or medical services, business support services, advisory or research services in any field, industrial or project consultancy and outsourcing activities of any nature.
Founded
1956
CEO
Ajaykumar Bholanath Gupta
Employees
2
HQ
Ahmedabad, Gujarat
About IEL Ltd
IEL is in the business of manufacturing, trading and marketing of all kinds of chemicals, pharmaceuticals, drug intermediates etc., as also is into the business or trade or activities of providing services in the areas of warehousing, leasing, renting, hire-purchase, market support services, distributors, information technology consultancy or related products, health or medical services, business support services, advisory or research services in any field, industrial or project consultancy and outsourcing activities of any nature.
Founded:1956
CEO:Ajaykumar Bholanath Gupta
Employees:2
HQ:Ahmedabad, Gujarat
Finished Products
1Sale of Products
₹23.27CrRaw Materials
1Finished Goods Purchases
₹17.38Cr2Purchases of Stock in Trade
₹3.88CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹10
52W Low
₹5
Volume21.34K
Avg VolumeN/A
Beta0.08
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
52.45x
Valuation
P/B Ratio
1.67x
Valuation
EPS
₹0.11
Valuation
Dividend Yield
0.00%
Valuation
ROE
0.41%
Profitability
ROCE
0.72%
Profitability
Revenue by Segment
Contribution & growth by business line
Trading in ChemicalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-15.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.